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Abstract
NF-kB and inflammasomes both play central roles in orchestrating anti-pathogen responses by rapidly inducing a variety of
early-response cytokines and chemokines following infection. Myxoma virus (MYXV), a pathogenic poxvirus of rabbits,
encodes a member of the cellular pyrin domain (PYD) superfamily, called M013. The viral M013 protein was previously
shown to bind host ASC-1 protein and inhibit the cellular inflammasome complex that regulates the activation and
secretion of caspase 1-regulated cytokines such as IL-1b and IL-18. Here, we report that human THP-1 monocytic cells
infected with a MYXV construct deleted for the M013L gene (vMyxM013-KO), in stark contrast to the parental MYXV, rapidly
induce high levels of secreted pro-inflammatory cytokines like TNF, IL-6, and MCP-1, all of which are regulated by NF-kB. The
induction of these NF-kB regulated cytokines following infection with vMyxM013-KO was also confirmed in vivo using THP-1
derived xenografts in NOD-SCID mice. vMyxM013-KO virus infection specifically induced the rapid phosphorylation of IKK
and degradation of IkBa, which was followed by nuclear translocation of NF-kB/p65. Even in the absence of virus infection,
transiently expressed M013 protein alone inhibited cellular NF-kB-mediated reporter gene expression and nuclear
translocation of NF-kB/p65. Using protein/protein interaction analysis, we show that M013 protein also binds directly with
cellular NF-kB1, suggesting a direct physical and functional linkage between NF-kB1 and ASC-1. We further demonstrate
that inhibition of the inflammasome with a caspase-1 inhibitor did not prevent the induction of NF-kB regulated cytokines
following infection with vMyxM013-KO virus, but did block the activation of IL-1b. Thus, the poxviral M013 inhibitor exerts a
dual immuno-subversive role in the simultaneous co-regulation of both the cellular inflammasome complex and NF-kB-
mediated pro-inflammatory responses.
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Introduction
The nuclear factor kB (NF-kB) family comprise a set of related
transcription factors that regulate multiple cellular pathways
associated with immune responses, inflammation, apoptosis, cell
growth and survival [1,2]. The mammalian NF-kB family
members include NF-kB1 (p105 and p50), NF-kB2 (p100 and
p52), RelA (p65), RelB and c-Rel, which become activated by
upstream signals from diverse immune receptors, such as ligand-
triggered Toll-like receptors (TLRs), interleukin-1 receptor (IL-
1R), tumor necrosis factor receptor (TNFR) and antigen receptors
[3,4]. However, their activation is tightly regulated by another
family of proteins known as inhibitors of NF-kB( I kBs), which are
also associated with the regulation of these diverse cellular
processes [5]. In unstimulated cells, NF-kB proteins remain
inactive in the cytoplasm, usually as homodimers or as
heterodimers with RelA, RelB or c-Rel and complexed with the
inhibitory IkBs. The IkBs are in turn regulated by another group
of regulatory proteins called IkB kinases (IKKs). The IKK
complex is composed of two catalysis subunits (IKKa and IKKb)
and a regulatory subunit IKKc, or NEMO (NF-kB essential
modulator) [6,7,8]. Upon ligand engagement, the receptors initiate
signal transduction events that lead to the activation of IKK
complex by activated cellular protein kinases like NF-kB-inducing
kinase (NIK), mitogen-activated protein/extracellular signal-regu-
lated kinase1 (MEKK1), transforming growth factor-b (TGFb)-
activated kinase 1 (TAK1), MEKK2 or MEKK3. Activated IKK
phosphorylates IkBa using specific serine residue within the IkBa
proteins, triggering their ubiquitination via ubiquitin ligase [9].
The IkBa protein is then degraded by the 26S proteasome,
allowing the release and translocation of the active NF-kB dimer
into the nucleus to upregulate targeted gene transcription events
[10,11].
Subversion of the host cell NF-kB signaling is a key strategy
adapted by many pathogens because this pathway regulates the
expression of multiple cellular host response proteins such as anti-
viral cytokines, chemokines and the presentation of viral antigens
to cytotoxic T lymphocytes [12,13,14]. Amongst viruses, members
of the poxvirus family are known to target and downregulate NF-
kB signaling in multiple ways. One strategy is to directly block the
primary immune ligands, particularly cytokines, chemokines or
IFNs, and thus prevent binding and activation of their cognate
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are secreted homologs of corresponding cellular receptors [15,16].
Another strategy is to deploy viral proteins to target the
components of the intracellular NF-kB signaling pathways [17].
For example, vaccinia virus (VACV), the prototypic member of
the poxviridae family and the most extensively studied poxvirus,
encodes multiple proteins to inhibit the intracellular NF-kB
pathway at different steps of the signaling cascade. For example,
VACV-encoded proteins A52R and A46R inhibit the interleukin 1
receptor (IL-1R) and toll-like receptor (TLR) signaling pathway
linked to the NF-kB complex [18,19]. A52R inhibits NF-kB
activation by interaction with interleukin 1 receptor-associated
kinase 2 (IRAK2) and tumor necrosis factor receptor associated
factor (TRAF6) [20]. B14R was recently shown to bind the IKK
complex and prevent phosphorylation of the IKKb activation loop
[21]. Another VACV protein, N1L, also targets the IKK complex
and interferes with both NF-kB and interferon regulatory factor 3
(IRF3) signaling [22]. Among the other VACV proteins, K1L
inhibits NF-kB activation by blocking degradation of IkBa [23]
while M2L downregulates ERK-mediated NF-kB induction in
infected cells [24]. Another poxvirus, molluscum contagiosum
virus (MOCV), also encodes multiple proteins, for example
MC159 and MC160, which regulate the NF-kB signaling
pathways [25,26,27].
Myxoma virus (MYXV) is a member of the leporipoxvirus
genus of the poxviridae family and causes lethal disease myxomatosis
in European rabbits (Oryctolagus cuniculus) [28]. MYXV encodes
diverse secreted and intracellular immunomodulatory proteins to
overcome host immune defenses [29]. However, unlike most of the
members of the orthopoxvirus genus, MYXV does not express any
predicted secreted proteins that directly bind and neutralize pro-
inflammatory cytokines such as IL-1b and IL-18, which are
regulated by a series of cellular multi-protein complexes
collectively termed inflammasomes [30,31,32]. Instead, the
MYXV-encoded protein M013, which was first identified as a
member of the PYRIN domain (PYD) superfamily, was shown to
function as an intracellular inhibitor of inflammasome activation
[33]. The cellular PYD-containing proteins mediate protein-
protein interactions with components of signaling pathways
involved in the regulation of apoptosis, NF-kB activation and
pro-inflammatory cytokine production [34,35]. Our initial study
showed that a MYXV construct deleted for M013L (vMyxM013-
KO) was significantly attenuated in host rabbits because of
decreased virus dissemination and enhanced inflammatory
responses at the tissue sites of virus infection [33]. The
vMyxM013-KO virus was unable to productively infect rabbit
monocytes or lymphocytes due to an abortive phenotype,
compared to parental MYXV. M013 protein was also shown to
directly interact with apoptosis-associated speck-like protein
containing CARD-1 (ASC-1), a component of the cellular
inflammasome complex and inhibited caspase-1 activation and
the processing of pro-inflammatory cytokines IL-1b and IL-18
[33].
In the present study, we report that infection of human THP-1
monocytic cells with the vMyxM013-KO virus, unlike the parental
MYXV, unexpectedly induced rapid and dramatic secretion of
diverse pro-inflammatory cytokines such as TNF, IL-6 and MCP-
1, all of which are regulated by NF-kB. THP-1 cells infected with
vMyxM013-KO virus, but not the parental MYXV, activated the
IKK kinases and degradation of IkBa at very early time of
infection, resulting in the activation and nuclear translocation of
NF-kB. We further demonstrate that the expressed M013 protein
alone interacts directly not only with ASC-1, but also with host
NF-kB1 and inhibits the translocation of p65 to the nucleus. We
conclude that the viral PYD-containing M013 protein can
simultaneously bind and co-regulate key components from both
the inflammasome complex and NF-kB-mediated signaling
pathways.
Materials and Methods
Reagents and antibodies
Recombinant TNF was purchased from Biosource. Rabbit
polyclonal antibodies (pAb) for IkBa, phospho-IkBa, p65, NF-
kB1, IKKa/b, phospho-IKKa/b, were purchased from Cell
Signaling Technology. HRP-conjugated goat anti-rabbit and anti-
mouse IgG antibodies were purchased from Jackson Lab. Phorbol-
12-myristate-13-acetate (PMA), LPS (lipopolysaccharide), and
caspase-1 inhibitor zVAD-fmk were purchased from Sigma.
ERK1/2 inhibitor U0126 and PI3kinase inhibitor LY294002
were purchased from Cell Signaling technology.
Plasmid construction
Cloning strategies used are based on the Gateway cloning
technology (Invitrogen). The M013L ORF of myxoma virus was
PCR amplified from the virus genome using Pfu Ultra polymerase
(Stratagene) and cloned in the Gateway entry vector pDONR221
(Invitrogen) using BP Clonase enzyme mix (Invitrogen). M013L
ORF lacking the PYD (1–81 amino acids) was constructed by
PCR amplification using appropriate primers and cloned in the
entry vector pDONR221. Both human RelA and NF-kB1 cDNAs
(Open Biosystems) were PCR amplified and cloned in
pDONR222 vector (Invitrogen). The resultant entry clones were
subsequently cloned in expression vectors pANT7_cGST,
pANT7_nHA [36], pcDNA3.1MycHis and pDEST40 (Invitro-
gen) using the LR Clonase II enzyme mix (Invitrogen).
Cell lines and cell culture
BGMK, 293T, BSRT7/5 (BHK cells expressing T7 polymer-
ase) [37] cells were cultured in DMEM supplemented with 10%
heat-inactivated fetal bovine serum (FBS), 2 mM L-glutamine,
100 U/ml penicillin and 100 mg/ml streptomycin (pen-strep).
THP1 cell line was cultured in RPMI 1640 medium (Lonza)
supplemented with 10% FBS and pen-strep. For differentiation,
THP1 cells were stimulated for 18 h (hour) with 100 ng/ml PMA.
Author Summary
Myxoma virus (MYXV), a rabbit-specific poxvirus pathogen,
encodes diverse immunomodulatory proteins that can
collectively overcome essentially all of the host immune
defenses. MYXV-encoded protein M013, a member of the
cellular PYRIN domain-containing superfamily of proteins,
was previously shown to be important for virus virulence
by blocking inflammasome regulated pro-inflammatory
cytokine secretion. Here, we report that, in addition to
targeting the ASC-1 protein of the host cell inflammasome
complex, M013 also blocks activation of NF-kB signaling
pathway by interacting with NF-kB1 and preventing
nuclear translocation of the transcription factor RelA/p65.
MYXV virus lacking a functional M013L gene (vMyxM013-
KO) induced the early activation of NF-kB signaling
pathway in human monocytic cells, causing the secretion
of antiviral pro-inflammatory cytokines in vitro and in vivo.
These results demonstrate that MYXV protein M013 is a
multifunctional immunosubversive protein that co-regu-
lates both the inflammasome complex and the NF-kB
signaling pathway simultaneously.
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Construction of a wild-type myxoma virus (vMyx-gfp) that
expresses a GFP cassette under the control of a synthetic VACV
early/late promoter was described previously [38]. Construction
of the vMyxM013-KO virus was previously described [33].
Viruses were purified by centrifugation through a sucrose cushion
and two successive sucrose gradient sedimentations as described
previously [39].
Transfections and luciferase assays
HeLa cells (1610
4) were seeded at 50% confluence onto 96-well
plates the day before being transfected. Cells were transfected
according to the manufacturer’s protocol using 0.5 ml Lipofecta-
mine 2000 reagent (Invitrogen) and 0.2 mg DNA, in serum-free
minimum essential medium (MEM), per each well. The DNA was
a 1:1:1 mix of NF-kB reporter vector to constitutive expression
vector to viral protein expression vector. The NF-kB reporter
vector used was the Stratagene (La Jolla, CA) pNFkB-Luc
plasmid, which gives inducible NF-kB-dependent expression of
firefly (Photinus pyralis) luciferase driven by a synthetic promoter
comprising a TATA box preceded by five direct repeats of the
sequence 59-TGGGGACTTTCCGC-39 containing the NF-kB
binding element first identified in the kappa light chain gene
enhancer [40]. The constitutive expression vector used was the
Promega (Madison, WI) pUCbased pRL-TK vector, which gives
low-level constitutive expression of sea pansy (Renilla reniformis)
luciferase from the promoter of the herpes virus thymidine kinase
gene. M013L ORF was cloned in pcDNA3.1MycHis vector
(Invitrogen) that gives a constitutive level of protein expression
from the CMV promoter [33]. At 6 h post-transfection, FBS was
added to the medium for a final concentration of 10%. At 48 h
post-transfection, the cells were treated with 20 ng/ml TNF for
6 h. To determine luciferase values, the Promega Dual-Luciferase
Reporter Assay System was used according to the manufacturer’s
instructions, with slight modifications. Briefly, the medium was
removed and the cells were washed once with 50 ml PBS and the
cells were lysed in 20 mlo f1 6 passive lysis buffer (Promega) for
15 min at room temperature. The lysates were then analyzed for
firefly and sea pansy luciferase activity. For luciferase value
determination, 100 ml of luciferase assay reagent II (Promega)
were added to the cell lysate and analyzed for firefly luciferase
activity using the Appliskan multimode microplate reader
(Thermo Scientific). Then 100 ml of Stop & Glo reagent (Promega)
were added for determination of sea pansy luciferase activity. The
relative fold changes were determined by normalizing the ratios of
firefly to sea pansy luciferase activities in each transfected cell
group to the value obtained for non-transfected cells.
Western blotting
For detection of protein, cells were harvested at different time
points, washed with PBS and stored at 280uC or processed
immediately with RIPA lysis buffer (50 mM Tris, 150 mM NaCl,
0.1% SDS, 0.5% sodium deoxycholate, 1% NP40, 1 mM PMSF,
protease inhibitor cocktail (Roche)). Protein samples were
separated on SDS-PAGE gels and transferred to PVDF mem-
brane (GE Healthcare) using a semidry transfer apparatus (Fisher).
Membranes were blocked in TBST (20 mM Tris, 150 mM NaCl,
0.1% Tween-20 pH 7.6) containing 5% non-fat dry milk for 1 hr
at room temperature and then incubated overnight with primary
antibody at 4uC. The membranes were washed three times,
15 minutes each with TBST and incubated with HRP-conjugated
goat-anti-mouse(1:5000) or goat-anti-rabbit (1:5000) secondary
antibody in TBST containing 5% non-fat dry milk for 1 hour at
room temperature with gentle agitation. The membranes were
washed three times, 15 minutes each with TBST, and the signal
was detected following the application of chemiluminescence
substrate (Pierce) and exposure to X-ray film (Eastman Kodak).
Quantification of cytokine secretion by ELISA
THP-1 cells were plated in multi-well plates in the presence of
PMA (100 ng/ml) for 12–18 h. The following day, media were
replaced with fresh media and the cells were either infected with
WT myxoma and vMyxM013-KO viruses (at MOI of 3) or treated
with LPS and the supernatants were collected at different time
points. Whenever mentioned, inhibitors were added one hour
before viral infection. The level of secreted cytokines TNF, IL-1b,
IL-6, IL-12 and MCP-1 were determined using ELISA assay kits
(eBioscience) following manufacturer protocol.
In vitro transcription/translation of plasmid constructs
The rabbit reticulolysate coupled transcription and translation
(TnT) system (Promega) was used according to manufacturer’s
protocol for expression of proteins in vitro. Protein expression was
confirmed by running 2.5 ml of the TnT reaction on SDS-PAGE
gels followed by western blot analysis using anti-GST antibody
(Neomarkers) for the GST-tagged protein and anti-HA antibody
(Santa Cruz) for the HA-tagged protein.
AlphaScreen protein interaction assay
The Amplified Luminescent Proximity Homogeneous Assay
(AlphaScreen
TM; PerkinElmer) [41,42] is a bead-based technology
for screening biomolecular interactions in a microplate format
[43]. The assay was performed in 384-well white opaque optiplates
(Perkin Elmer) in a total volume of 25 ml. BSR T7/5 cells were
used for expression of tested proteins. Cells were seeded onto 24-
well plates one day before transfection. Cells were then transfected
according to the manufacturer’s protocol using 2 ml Lipofectamine
2000 reagent (Gibco BRL) and 0.8 mg total DNA (equal amounts
of host and viral DNA), in serum-free MEM, per each well. The
expression vectors used were either the pcDNA3.1MycHis plasmid
(Invitrogen), for the host proteins, or the pANT7_cGST plasmid
(Harvard Institute of Proteomics), for the viral protein. Expression
from the pcDNA3.1MycHis plasmid is under the control of either
CMV or T7 RNA polymerase promoter and the expressed
proteins are fused at their C-terminal with both Myc and His tags.
On the other hand, expression from the pANT7_cGST plasmid is
under the control of T7 RNA polymerase promoter and expressed
proteins are fused at their C-terminal with a glutathione-S-
transferase (GST) tag. Forty eight hours post transfection, cells
were collected in 500 ml PBS, pelleted and then lysed by
suspending in 20 ml lysis buffer (100 mM NaCl, 100 mM Tris,
pH 8.0, 0.5% NP-40, containing 25 ml/ml Roche complete
protease inhibitor). The cellular extracts were then separated
following centrifugation for 5 min at 13,000 rpm.
All dilutions were made in phosphate buffered saline (PBS;
3.2 mM Na2HPO4, 0.5 mM KH2PO4, 1.3 mM KCl, 135 mM
NaCl, pH 7.4) containing 0.1% bovine serum albumin (BSA). Five
ml of anti-GST acceptor beads (PerkinElmer, 6760603C), diluted
50-fold (20 mg/ml final concentration of beads in assay) in 0.1%
BSA/PBS assay buffer, and 5 ml of cell extract were mixed to a
final volume of 20 ml with 0.1% BSA/PBS assay buffer, and
incubated at room temperature for 1.5 hour. Subsequently, 5 mlo f
Nickel Chelate donor beads (PerkinElmer, AS101D), diluted 50-
fold in 0.1% BSA/PBS assay buffer (20 mg/ml final concentration
of beads in assay), were added to a final volume of 25 ml and
incubation was continued for another 1.5 hour at room temper-
ature. All additions and incubations were performed under
subdued lighting conditions due to the photosensitivity of the
Co-Regulation of NF-kB and Inflammasome by M013
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reader (PerkinElmer).
Detection of protein-protein interaction using ELISA
A modified Enzyme-linked immunosorbent assay (ELISA) was
used for in-vitro protein-protein interaction studies. The 384-well
ELISA plates were coated with a rabbit polyclonal anti-GST
antibody (Neomarkers), diluted 1 to 400 in coating buffer
(0.138 M NaCl, 0.0027 M KCl, pH 7.4), overnight at 4uCi n
25 ml volume. Following incubation, the antibody was removed
and wells were blocked overnight with 5% non-fat milk in PBS.
Blocking buffer was removed and wells were washed 5 times with
100 ml washing buffer (PBS containing 1% BSA and 0.05%
Tween 20). Both viral and host proteins were expressed, either
individually or in combination, using the TnT in vitro expression
system following manufacturer’s protocol. Either 1.25 ml or 2.5 ml
(for individually expressed or co-expressed proteins, respectively)
of each TnT reaction was then applied, per well, to the anti-GST
antibody coated plate and incubated for 2 hr at room tempera-
ture. The wells were then washed 5 times with washing buffer.
Assembly of the protein complex in the wells was then assessed
through the incubation of HRP-conjugated rat anti-HA antibody
(1:500 dilution) (Roche) in 25 ml volume for 2 hr at room
temperature. The unbound antibody was removed by washing
the wells 5 times with washing buffer. Binding of the second
antibody (HRP-conjugated anti-HA) to the protein complex was
then detected by applying 50 ml of TMB substrate. The reaction
was stopped by adding 25 mlo f2NH 2SO4 to each well. The plate
was read at 450 nm using a multi-well plate reader.
Immunofluorescence confocal microscopy
HeLa cells (3610
4) plated on coverslips were either mock
transfected or transiently transfected with 2 mgo f
pcDNA3.1M013L or pDEST40M013DPYD DNA. Cells were
mock treated or treated with 20 ng/ml TNF for 30 min at 37uCa t
24 hr post transfection. Coverslips were then washed with PBS
and fixed with 2% paraformaldehyde (Sigma) for 12 minutes,
permeabilized with 1% NP40 (Sigma) and blocked with 3% BSA
in PBS. Coverslips were incubated with both rabbit anti- p65 (sc-
372; Santa Cruz) and mouse anti-Myc (sc-40; Santa Cruz) or
mouse anti-V5 (Invitrogen) diluted 1:100 in PBS containing 3%
BSA for 30 minutes at 37uC. Coverslips were incubated in these
secondary antibodies: goat anti-rabbit-Texas-Red and goat anti-
mouse- fluorescein isothiocyanate diluted at 1:750 in PBS
containing 3% BSA for 30 minutes at 37uC in the dark. Following
staining, coverslips were mounted on microscope slides with 7.5 ml
Vecta-shield mounting media with DAPI (49,6 diamidino-2-
phenylindole; Vector Laboratories, Burlingame, CA, USA) for
visualization of nuclei. Cells were visualized using the 40X
objective of an Olympus DSU-IX81 Spinning Disc Confocal/
Deconvolution fluorescent microscope.
In vivo infections of THP-1 tumor xenografts
Xenografted THP-1 tumors were generated by implanting
THP-1 cells (5610
6 in 100 ml PBS) subcutaneously (s.c) on the left
hind leg of 6–8 week old female NOD-SCID mice (Charles River).
Tumor growth was monitored every other day. On day 6 after
tumor cell implantation, a single dose of MYXV or vMyxM013-
KO (1610
8 ffu virus in 100 ml volume) was injected directly in the
tumor. The animals of the control group were injected with PBS
into the tumor. After 48 h following virus injection, the animals
were sacrificed and both blood and tumor tissues (suspended in
PBS) were collected. The levels of secreted human cytokines in
serum and tumor tissues were determined by ELISA as described
before. All animal studies were performed in compliance with the
regulations of the University of Florida Animal Care Services in
accordance with the guidelines set by the Association for
Assessment and Accreditation of Laboratory Animal Care.
Results
Induction of an early pro-inflammatory cytokine
secretion by vMyxM013-KO virus infection of THP-1 cells
The vMyxM013-KO virus was markedly attenuated in infected
rabbits due to enhanced inflammatory responses at sites of
infection, suggesting that M013 was involved in regulating host
inflammatory responses to the virus infection [33]. Since many
MYXV-encoded modulators are able to recognize and inhibit host
proteins from a wide variety of species, particularly if the host
protein targets are well conserved, this phenomenon was further
investigated in cultured human monocytic THP-1 cells, where the
secretion of the inflammasome-controlled cytokines IL-1b and IL-
18 was previously shown to be inhibited by M013 protein. The
PYD domain of M013 was critical for the protein/protein
interaction with host ASC-1 protein, the common adapter protein
of inflammasome complexes, and prevented caspase-1-mediated
activation and secretion of these cytokines in response to MYXV
infection [33]. It has been reported that some cellular PYD-
containing regulatory proteins can co-modulate the function of
both inflammasomes and NF-kB [44,45]. To determine whether
M013 might also regulate the secretion of other pro-inflammatory
molecules under NF-kB control, human THP-1 cells were infected
with either wild-type (WT) MYXV or vMyxM013-KO virus and
the cell supernatants were harvested at various time post infection
to measure various indicator cytokines and chemokines by ELISA.
The THP-1 cells were first treated with PMA to promote
monocytic differentiation and then infected with the test viruses.
When checked for virus replication in THP-1 cells both the test
viruses were substantially compromised in production of progeny
virions (data not shown). As a positive control, THP-1 cells were
treated with LPS, a known TLR-mediated activator of NF-kB and
inducer of many pro-inflammatory cytokines. In order to monitor
early inflammatory cytokine responses, the supernatants were
collected starting from 15 minutes after addition of virus to the
cells. As shown in Fig. 1A, infection of THP-1 cells with
vMyxM013-KO virus significantly increased IL-1b secretion
within one hour, compared to control MYXV, indicating that
the vMyxM013-KO virus was uniquely unable to block the
inflammasome/caspase 1-mediated response to the virus infection.
When tested for induction of an NF-kB controlled cytokine such as
TNF, this cytokine level was also significantly increased within one
hour, specifically in case of vMyxM013-KO virus infection but not
WT-MYXV (Fig. 1B). The secretion levels of both cytokines
quickly rose and co-ordinantly reached a maximum within 2 to
4 hours of infection. LPS treatment of uninfected THP-1 cells also
co-induced the secretion of IL-1b and TNF to comparable levels
(data not shown), suggesting that infection with vMyxM013-KO
virus was as comparably robust at inducing these two cytokines as
the triggering of TLR4 activation with LPS. To assess whether
infection with the M013L-minus variant of MYXV induced
broader effects on other pro-inflammatory cytokines, the infected
THP-1 cell supernatants were also tested for IL-6, IL-12 and the
CC chemokine MCP-1 by ELISA. Compared to TNF and IL-1b,
the secretion of IL-6 and MCP-1 by THP-1 cells infected with
vMyxM013-KO virus was first detected much later, and these
were only measurable after 12 hours post infection (Fig. 1C and
D). The second wave of vMyxM013-KO virus-mediated cytokine
induction might be the effect of other cytokines like TNF or IL-1b.
Co-Regulation of NF-kB and Inflammasome by M013
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time point induced only minimal secretion of any of these
cytokines. In case of LPS treatment of THP-1 cells, the induction
of IL-6 and MCP-1 also began after a delay, but was first
detectable after 8 hours of treatment (data not shown). Also, we
did not observe any detectable induction of IL-12 and type I
interferon (IFNa and IFNb) secretion following infection of THP-1
cells with either MYXV or vMyxM013-KO viruses (data not
shown). Analysis of the cytokine mRNA levels using real-time PCR
revealed a similar induction of cytokine mRNA levels following
Figure 1. Kinetics of cytokine secretion in virus-infected THP-1 cells in vitro and in vivo. THP-1 cells were differentiated for 12–18 h with
PMA and then infected with MYXV or vMyxM013-KO viruses, at MOI of 3. Cell supernatants were collected at indicated time points to measure
secretion of A) IL-1b, B) TNF, C) IL-6 and D) MCP-1 by ELISA. E) Level of human TNF secretion from virus infected THP-1 tumor xenografts implanted in
NOD/SCID mice by s.c injection. Virus was injected intratumorally after 7 days of implantation and tissues were collected after 48 h of virus injection.
TNF was detected by ELISA.
doi:10.1371/journal.ppat.1000635.g001
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These results indicate that, in addition to promoting inflamma-
some activation, infection of THP-1 cells with the M013-knockout
MYXV also specifically triggered the induction of various early
pro-inflammatory cytokines and chemokines that are regulated by
NF-kB.
We next examined whether vMyxM013-KO virus can also
induce comparable pro-inflammatory cytokine production in vivo,
using THP-1 derived monocytic tumors established by engraft-
ment into immunodeficient NOD/SCID mice. MYXV is
currently being developed as an oncolytic therapeutic treatment
for human cancer, and the WT virus replicates similarly within
xenografted human tumor tissues in situ as it does within normal
rabbit tissues [46]. Thus, to model MYXV behavior within
susceptible tissues for which the appropriate cytokine reagents are
currently available, engrafted THP-1 cells were used to generate
monocytic tumors in NOD-SCID mice, which were first detected
at 6 days after subcutaneous injection on the left hind leg. At this
point, samples of either MYXV or vMyxM013-KO virus were
injected intra-tumorally on day 7 and tissues were collected after
48 h post-virus injection for cytokine induction measurements.
Significantly, we observed that tumors infected with vMyxM013-
KO virus, but not WT-MYXV or mock PBS-injected control
tumors, selectively induced significant levels of human TNF
(Fig. 1E). However, we were not able to detect newly induced
human IL-1b from any of these tissue samples (data not shown).
Due to the localized nature of the THP-1 tumors and the virus
injection route, we also could not detect any selectively induced
human cytokines in the serum samples from any of the mice at this
time point. This result suggests that vMyxM013-KO virus, but not
WT-MYXV, can specifically induce NF-kB mediated TNF
directly within susceptible tissue sites in vivo as well as in vitro.
Activation of early NF-kB-mediated inflammatory
responses by vMyxM013-KO virus infection
The transcription factor NF-kB has been shown to play an
essential early role in virus-induced expression of diverse pro-
inflammatory cytokines, interferons and chemokines in infected
cells. We next investigated how the innate NF-kB pathway was
activated in response to vMyxM013-KO virus infection, which then
leads to the secretion of pro-inflammatory cytokines under NF-kB
control. Activation of NF-kB is usually regulated by the inhibitor
IkBa, which is itself often the immediate target of viral subversion.
In response to upstream stimulatory signals such as virus infection,
IkBa becomes phosphorylated by cellular kinases and then is
degraded by the proteasome following ubiquitination. This loss of
IkBa repression then triggers the translocation of NF-kB to the
nucleus to initiate target gene transcription. To determine whether
increased NF-kB-driven gene transcription occurs specifically in
response to vMyxM013-KO virus infection, and whether this
resulted from loss of IkBa, we investigated the degradation of IkBa
in virus-infected THP-1 cells by Western blot analysis. THP-1 cells
wereinfected withWT-MYXVor vMyxM013-KO virus, harvested
at different time points and the level of IkBa was assessed. By one
hour post infection, we observed a transient reduction in IkBa
uniquely in the cells infected with vMyxM013-KO virus, but the
IkBa levels were fairly similar at later time points following either
WT-MYXV or vMyxM013-KO virus infection (Fig. 2A). We then
investigated the first hour post-infection in greater detail, and
observed that within the first 15 minutes of vMyxM013-KO virus
infection of the THP-1 cells, the cellular pool of IkBa was almost
completely degraded (Fig. 2B, 2
nd row). However, in WT-MYXV -
infected cells the level of IkBa remained essentially the same as
mock infected THP-1 cells (Fig. 2B, 1
st and 4
th rows). Following this
rapid degradation, the level of IkBa in the vMyxM013-KO virus
infected cells then recovered and returned to normal levels within
2 hr post infection. As a comparison, we also measured the kinetics
of LPS- induced degradation of IkBa in THP-1 cells (Fig. 2B, 3
rd
row).InLPS-treatedcells,thedegradationofIkBawasfirstdetected
later, beginning at 30 min and the protein level continued to
decrease up to 2 h post treatment, which is dramatically different
from the rapid degradation induced following infection with
vMyxM013-KO virus.
As the degradation of IkBa is mediated by the kinetics of its
phosphorylation, we next investigated the phosphorylation state of
IkBa in virus-infected THP-1 cells by Western blot analysis. The
induction of phosphor-IkBa (p-IkBa) was readily detected at 0.5 and
2 hours after infection of THP-1 cells with vMyxM013-KO virus but
not WT-MYXV (Fig. 2C). This suggests that degradation of IkBa in
vMyxM013-KO-infected THP-1 cells is mediated by its phosphor-
ylation, as it is by other nonviral inducers of NF-kB activation.
Phosphorylation of IKK following vMyxM013-KO virus
infection
It is evident that vMyxM013-KO virus can induce early pro-
inflammatory responses in THP-1 cells by rapidly inducing the
phosphorylation and degradation of IkBa, which should trigger
Figure 2. Activation of early inflammatory responses by
vMyxM013-KO virus. THP-1 cells were differentiated with PMA and
infected with MYXV or vMyxM013-KO viruses, at MOI of 3 or treated
with LPS (1 mg/ml) for indicated time points and harvested to prepare
total cell extracts. Equal amounts of protein from uninfected, infected
or LPS treated cells were analyzed by Western blot using IkBa (A and B)
and phospho IkBa (pIkBa) (C) antibodies.
doi:10.1371/journal.ppat.1000635.g002
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transcription. We next investigated whether the multi-component
IKK complex becomes activated in THP-1 cells in response to
vMyxM013-KO infection and subsequently degraded the IkBa.
The virus-infected THP-1 cells were harvested at different time
points, and examined for IKKa/b or p-IKKa/b by Western blot
analysis. In response to vMyxM013-KO virus infection, we
observed a rapid elevation in the phosphorylation levels of IKKa
and IKKb, as compared to the WT-MYXV infections (Fig. 3A).
The level of total IKKa/b protein was very similar when
comparing the two viruses (Fig. 3B). However, the antibody used
to detect the phosphorylated IKK also reacted with a non-specific
protein in all the test samples. Based on this observation we
conclude that early phosphorylation of IKK by vMyxM013-KO
virus mediates the activation of NF-kB pathway.
NF-kB nuclear translocation following vMyxM013-KO
infection of THP-1 cells
We next investigated the mechanism of NF-kB-mediated
activation of pro-inflammatory cytokine production in the virus-
infected THP-1 cells. Among the NF-kB family members, NF-kB1
(p105 and p50) and RelA (p65) have so far been linked with virus-
induced expression of pro-inflammatory target gene expression. In
unstimulated cells, NF-kB1-p105 remains in the cytoplasm as a
dimer with RelA/p65, c-Rel or p50. In response to activating
stimuli, p105 becomes phosphorylated by kinases and is degraded
to release the associated Rel or p50 subunit [47]. The p50 and p65
heterodimeric complex then translocates to the nucleus after
degradation of IkBa and initiates transcription of target pro-
inflammatory genes. To deduce how M013 might perturb this
activation pathway, we first examined the cleavage of p105 in
virus-infected THP-1 cells. The cells were infected with either
WT-MYXV or vMyxM013-KO and harvested at 30 min and
2 hr for detection of protein by Western blot analysis. Infection of
THP-1 cells with vMyxM013-KO virus induced the rapid
degradation of NF-kB1-p105 and the NF-kB1-p50 form can be
detected (Fig. 4A). However, in the WT-MYXV infected THP-1
cells, both p105 and p50 can be readily detected. The level of the
p65 subunit, however, in case of both virus infections remained
essentially unchanged (Fig. 4B). Thus, the expression of the M013
protein protects the p105 form of NF-kB1 from the degradation
associated with the canonical NF-kB activation pathway.
In order to determine whether the RelA/p65 complex is
correctly translocated to the nucleus, we prepared cytoplasmic and
nuclear fractions of mock and virus-infected THP-1 cells (30 min
after virus infection) and Western blot analysis was performed. In
response to vMyxM013-KO virus infection, the majority of the
p65 protein had migrated to the nucleus during early time points
of infection (Fig. 4C, right panel). The level of p50 also increased
in the nuclear fraction of vMyxM013-KO virus infection
compared to the mock and WT-MYXV infection (Fig. 4C, left
panel). As expected, no NF-kB1/p105 was detected in the nucleus
(not shown). As loading controls, levels of histone H1 (nuclear
extracts; Fig. 4C left middle panel) and actin (cytoplasmic extracts;
Fig. 4C right bottom panel) were examined. These results indicate
that, once THP-1 cells become activated by infection with
vMyxM013-KO virus, RelA/p65 rapidly translocates to the
nucleus, with kinetics similar to that triggered by many other
nonviral inducers.
vMyxM013-KO virus can induce inflammasome-
dependent and NF-kB-dependent cytokine secretions
independently
In THP-1 cells, vMyxM013-KO virus infection can co-
ordinantly induce inflammasome-mediated secretion of IL-1b,
and IL-18, as well as NF-kB -mediated secretion of various other
pro-inflammatory cytokines and chemokines. In order to deter-
mine whether these two pathways were activated independently or
through common mechanism, we used a specific inhibitor of
inflammasome activation to differentiate the two pathways.
Inflammasome-mediated secretion of IL-1b depends on activation
of caspase-1, which cleaves the pro-IL1b to produce active IL-1b
for secretion. Treatment of THP-1 cells with caspase-1 inhibitor,
zVAD-fmk, alone caused no induction of IL-1b but when
combined with the infection with vMyxM013-KO virus resulted
in the dramatic inhibition of IL-1b secretion at early time points,
starting in the first hour post-infection (Fig. 5A). When the same
samples were also tested for TNF secretion, we observed that
inhibition of caspase-1 with this inhibitor had no effect on
vMyxM013-KO virus-mediated induction of TNF (Fig. 5B). This
suggests that vMyxM013-KO virus-mediated early induction of
IL-1b secretion depends on inflammasome activation of caspase 1,
but in case of TNF, the induction is mediated by NF-kB and is
independent of caspase-1.
vMyxM013-KO virus induces MAP kinase dependent
secretion of pro-inflammatory cytokines in THP-1 cells
In order to test which cellular signaling pathway(s) might be
involved in the activation of NF-kB in response to vMyxM013-
KO virus infection, we used the kinase inhibitors U0126, an
ERK1/2 inhibitor and LY294002, a PI3 kinase inhibitor. THP-1
cells were pretreated with these inhibitors for one hour and
infected with WT-MYXV or vMyxM013-KO viruses. The
supernatants were collected at different time points after infection
and tested for secreted IL-1b and TNF by ELISA. Both the kinase
inhibitors had no effect on viral gene expression in this cell line
when compared to the untreated cells (data not shown). Treatment
of THP-1 cells with U0126 totally inhibited the vMyxM013-KO
virus-induced secretion of TNF, starting from early times of
Figure 3. Phosphorylation of IKKa/b following virus infection.
THP-1 cells were differentiated with PMA and infected with MYXV or
vMyxM013-KO viruses, at MOI of 3 for indicated time points and
harvested to prepare total cell extracts. Equal amounts of protein
loaded in SDS-PAGE to detect proteins by Western blot using A)
phospho IKKa/b and B) IKKa/b specific antibodies. The stars indicate the
phospho IKK protein bands.
doi:10.1371/journal.ppat.1000635.g003
Co-Regulation of NF-kB and Inflammasome by M013
PLoS Pathogens | www.plospathogens.org 7 October 2009 | Volume 5 | Issue 10 | e1000635infection (Fig. 6A). However, when the samples were tested for IL-
1b secretion, induction of this cytokine was also inhibited and after
two hours the cytokine level remains constant. This suggests that
U0126 did not totally abrogate the inflammasome-mediated
secretion of processed IL-1b from pre-existing stores of precursor
pro-IL-1b, but did effectively inhibit the NF-kB-mediated
production of precursor pro-IL-1b, which subsequently is
processed by inflammasome. When tested the uninfected and
infected THP-1 cells, U0126 totally inhibited the phosphorylation
of ERK1/2 and IKKa/b (data not shown). The PI3 kinase
inhibitor LY294002 did not inhibit the induction of either TNF or
IL-1b in response to vMyxM013-KO virus infection, indicating
that this pathway is not critical for induction of either cytokine in
response to vMyxM013-KO virus infection (Fig. 6B). This suggests
that vMyxM013-KO virus mediated activation of NF-kBi s
dependent on ERK1/2 kinase signaling but not the PI3 kinase
pathway.
M013 protein inhibits signaling pathways leading to
activation of NF-kB in the absence of virus infection
To investigate the direct effects of MYXV M013 protein on NF-
kB activation, the expression of the Firefly luciferase reporter gene
linked to a NF-kB dependent promoter was used to quantify
induction of the NF-kB signaling pathway. As an internal control,
Figure 4. Activation of NF-kB1 and nuclear translocation of NF-kB p65 by vMyxM013-KO virus. THP-1 cells were differentiated with PMA
and infected with MYXV or vMyxM013-KO viruses at MOI of 3 for indicated time points and harvested to prepare total cell extracts and nuclear and
cytoplasmic extracts. Equal amount of proteins were loaded in SDS-PAGE to detect the presence of A) NF-kB1; B) NF-kB p65 in the total cell extracts
and C) NF-kB1 and p65 in the nuclear (top panels) and cytoplasmic (bottom panels) extracts. The proteins were detected using specific antibodies.
doi:10.1371/journal.ppat.1000635.g004
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a constitutively active promoter (thymidine kinase, tk promoter)
was also examined. HeLa cells were co-transfected with the
plasmids expressing the reporter genes and M013L (under CMV
promoter) and then the cells were stimulated with TNF for
induction of NF-kB-dependent reporter gene expression. The
Firefly/Renilla Luciferase expression ratio was increased signifi-
cantly (about 12 fold) upon stimulation with TNF but this level was
reduced (about 50%) in the presence of transfected M013L
(Fig. 7A). Even with the caveats of incomplete transfection
efficiencies, these results demonstrated that PYD-containing
M013 protein specifically inhibits NF-kB-regulated gene expres-
sion even in the absence of any other MYXV gene products. This
result is in contrast to another report claiming that a related PYD-
containing poxviral protein from Shope fibroma virus, called
S013, induced the activation of NF-kB activity in a transient
transfection assay [48].
We next tested whether the expressed M013 protein inhibited
the nuclear translocation of p65/RelA after treatment with TNF.
HeLa cells were mock transfected or transiently transfected with
an expression plasmid that expressed Myc-His tagged M013
protein. Immunostaining of cells using anti-p65 antibody identified
the major location of this protein in the cytosol (Fig. 7B, panels a–
d), however, when the cells were induced with TNF, the p65
protein efficiently translocated to the nucleus (Fig. 7B, panel e–h).
In the absence of TNF stimulation, Myc-tagged M013 protein was
located mostly in the cytoplasm and formed characteristic
punctate bodies in the expressing cells (Fig. 7B, panels i–l). The
cells which expressed M013 protein uniquely exhibited the
property that TNF-induced nuclear translocation of p65/RelA
was blocked (Fig. 7B, panels m–p), suggesting that the direct
inhibitory effect of M013 protein on NF-kB relocation to the
nucleus. The ability of M013 to inhibit the TNF-induced nuclear
translocation of p65/RelA was further confirmed using a construct
lacking the PYD (Fig. 7C, panels a–h). These results suggest that
M013 protein in the absence of other viral proteins can inhibit NF-
kB-mediated gene transcription by blocking the translocation of
NF-kB p65 to the nucleus.
M013 protein physically interacts with NF-kB1 p105
To better understand how M013 protein prevents translocation
of RelA/p65 to the nucleus, we examined the physical interactions
between various NF-kB members and M013 protein using in vivo
and in vitro protein-protein interaction methods. In vivo interaction
was studied in transfected cells using the AlphaScreen method
[41,42]. Plasmids expressing GST-tagged M013 protein and Myc/
His tagged host proteins under a T7 promoter were co-transfected
in T7 polymerase-expressing BSRT7/5 cells and tested using
specific AlphaScreen beads. Interaction of M013 protein with
human NF-kB1 p105 protein was detected by emission floures-
cence whereas a control poxviral protein of a similar size (MYXV
M063) or vector control (Fig. 8A) did not. Using the same method,
however, we did not detect any interaction between M013 and
RelA/p65. The interaction of GST-tagged M013 and Myc/His
tagged NF-kB1 p105 was also confirmed by GST pulldown assay
after co-expression of the corresponding plasmids in the BSRT7/5
cells (data not shown).
The protein/protein interaction between M013 and NF-kB1-
p105 following expression in reticulocyte lysates was also
confirmed using an ELISA method. GST-tagged M013 protein
and HA-tagged host proteins were individually (as control) or co-
Figure 5. The effect of a specific caspase-1 inhibitor on
cytokine secretion from virus-infected THP-1 cells. THP-1 cells
were differentiated with PMA and treated with caspase-1 inhibitor
zVED-fmk (50 mM) for one hour and infected with MYXV or vMyxM013-
KO viruses at MOI of 3. Cell supernatants were collected at indicated
time points and tested for A) IL-1b and B) TNF by ELISA kit.
doi:10.1371/journal.ppat.1000635.g005
Figure 6. The effect of NF-kB signaling inhibitors on cytokine
secretion from virus-infected THP-1 cells. THP-1 cells were
differentiated with PMA and treated with ERK1/2 inhibitor U0126
(20 mM) and PI3kinase inhibitor LY294002 (20 mM) for one hour and
infected with MYXV or vMyxM013-KO viruses at MOI of 3. Cell
supernatants were collected at indicated time points and tested for
A) TNF and B) IL-1b by ELISA kit.
doi:10.1371/journal.ppat.1000635.g006
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PLoS Pathogens | www.plospathogens.org 9 October 2009 | Volume 5 | Issue 10 | e1000635Figure 7. M013 protein alone suppresses NF-kB activity and nuclear translocation of p65. (A) HeLa cells were co-transfected with equal
amounts of pNF-kB-Luc and tk-Renilla-Luc along with pcDNA3.1M013L Myc/His or empty vector. At 48 h post-transfection, cells were either left untreated
or treated with TNF (20 ng/ml) for 6 h and then assayed for both sea pansy and firefly luciferase activity. The presented values represent the average of
three independent transfections. (B) Immunofluorescence and confocal microscopy analysis demonstrating the effect of M013 on TNF-induced nuclear
translocationofNF-kB/p65inHeLacells.Mock(a–h)orM013L(i–p)transfectedHeLacellswerelabeledintheabsence(a–dandi–l)orpresence(e–handm–
p) of TNF treatment. (C) Immunofluorescence and confocal microscopy analysis demonstrating the effect of M013DPYD on TNF-induced translocation of
NF-kB/p65 in HeLa cells. M013DPYD transfected HeLa cells were labeled in the absence (a–d) or presence (e–h) of TNF treatment.
doi:10.1371/journal.ppat.1000635.g007
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PLoS Pathogens | www.plospathogens.org 10 October 2009 | Volume 5 | Issue 10 | e1000635Figure8.M013proteininteractswithNF-kB1 protein. A) BSR-T7/5cellswereco-transfectedwiththepcDNA3.1Myc/HisplasmidexpressingMyc/His-
tagged-NF-kB1 or RelA along with the pANT7_cGST plasmid expressing GST-tagged-M013, M063 or an empty pANT7_cGST plasmid. Following
transfection, cell lysates were subjected to the Alphascreen protein-protein interaction assay using Nickel-coated donor beads and anti-GST-coated
acceptor beads. The presented results represent the average of three independent transfections. Using in vitro TNT reactions GST-tagged M013 B) or
M013DPYDC)andHA-taggedNF-kB1 orRelA were expressedaloneor co-expressedfromappropriateplasmids.Theexpressedproteinswereboundto the
anti-GSTantibody coated 384 well plates. After washing the bound protein complexes were detected using anti-HA antibody and a HRP-coated secondary
antibody. The binding of secondary antibody was detected by applying TMB substrate. The plate was then read at 450 nm using a multiwell plate reader.
doi:10.1371/journal.ppat.1000635.g008
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tagged M013 viral protein was bound to the ELISA plate coated
with anti-GST antibodies and the interacting HA-tagged host
protein was detected using HRP conjugated anti-HA antibody.
Using this method, we could detect the interaction of M013 with
NF-kB1-p105, while RelA produced essentially no signal above
background (Fig. 8B). In addition, the pyrin domain was
specifically shown to be required for this interaction because
when this domain was deleted from M013, no binding with NF-
kB1 was detected (Fig. 8C). This confirmed that M013 protein can
associate directly with NF-kB1-p105 in the absence of any other
viral proteins.
Discussion
The MYXV-encoded M013 protein was first characterized as a
functional member of the cellular PYRIN domain (PYD)-
containing protein family that regulates the function of host
inflammasome complex [33]. The PYD domain is one of four
subfamilies of the death-domain fold superfamily of evolutionary
conserved protein-protein interaction domain containing proteins
[34,49]. PYD-containing proteins mediate homotypic and hetero-
typic interactions among family members and even proteins with
different domains, from other families. These diverse interactions
allow PYD-containing proteins to be associated with cellular
processes like apoptosis, immunity, inflammation, differentiation
and proliferation [34]. In humans, at least 23 PYD containing
proteins have been identified to date that fall in four groups: 1-
receptor proteins or pathogen recognition receptors (PRRs), that
recognize pathogen associated molecular patterns (PAMPs) known
as PAN, NALP (NACHT, LRR and PYD containing proteins),
PYPAF, NOD (nucleotide-binding oligomerization domain),
Caterpiller and NLR (NOD-like receptors) proteins [35,50,51];
2- adapter proteins like ASC-1 [52,53]; 3-regulatory proteins, for
example cellular PYD-only proteins (cPOPs) cPOP1 and cPOP2
[44,45,54] and, 4- IFN-inducible proteins known as 200-amino-
acid repeat (HIN-200) gene family [55].
The PYD-containing host proteins are predominantly expressed
in leukocytes and tissue sentinel cells and are integrated with
pathogen sensors that trigger the innate immune responses. The
common adapter protein ASC-1 contains bifunctional domains
PYD and CARD (C-terminal caspase-recruitment domain) which
interacts with the PYD-containing NALP proteins and CARD-
containing caspase-1, respectively, to activate pro-caspase-1 in the
NALP3-inflammasome complex [53]. ASC-1 also regulates
apoptosis and NF-kB signaling responses by interaction with
multiple other proteins in those pathways [52]. ASC-1, in turn, is
regulated by cellular and viral regulatory proteins, collectively
called POPs [33,44,45,48,54,56]. The cellular regulatory proteins,
cPOP1 and cPOP2, control the function of adapter protein ASC-1
by mediating PYD-PYD interactions. In addition to ASC-1,
cPOPs also can inhibit NF-kB activation [44,57]. M013 protein of
MYXV is an example of a functional viral POP (vPOP). M013
interacts directly with ASC-1 protein and modulates caspase-1
activation and IL-1b/IL-18 processing in cultured monocyte-
derived cells, such as THP-1 cells, and in infected rabbit tissues
[33]. A closely related vPOP protein from Shope Fibroma virus
was also shown to block the activation of pro-caspase-1 in transient
transfection assay and subsequent processing of pro-IL-1b [48].
Furthermore, infection of THP-1 cells with vMyxM013-KO virus
induced the activation of caspase-1 and processing and secretion of
pro-inflammatory cytokines IL-1b and IL-18 [33]. Here, we
demonstrate that vMyxM013-KO infection of THP-1 cells also
induces other cytokines and chemokines (TNF, IL-6, and MCP-1)
that are regulated by the NF-kB pathway, in addition to the
cytokines controlled by the caspase 1/inflammasome complex.
Both cPOP1 and cPOP2 have been shown to also exert
inhibitory properties for NF-kB signaling [44,45]. On the other
hand, PYD-containing pathogen receptors (PRRs) have diverse
effects on the function of NF-kB. Some of these are reported to
have NF-kB-mediated pro-inflammatory roles such as PYPAF1/
NALP3 [58], whereas others such as PAN2/PYPAF4 and PAN1/
PYPAF2 inhibited NF-kB [59]. The vMyxM013-KO virus-
mediated activation of NF-kB reported here suggests that the
M013 vPOP protein has a co-inhibitory role against both the
inflammasome complex and cellular NF-kB signaling, and binds
distinct protein targets from each pathway, namely ASC-1 and
NF-kB1.
One of the novel findings in this study is the rapid induction of
NF-kB-mediated inflammatory responses against vMyxM013-KO
virus, which is repressed by the WT-MYXV. Infection of THP-1
cells with vMyxM013-KO virus induced the formation of NF-kB
p50/p65 complex, which migrates to the nucleus to induce the
transcription of pro-inflammatory mediators. Indeed, transient
expression of M013 protein alone inhibited the TNF-induced NF-
kB activation by blocking the translocation of p65 to the nucleus.
The host cPOP2 also blocks the NF-kB activation in the same
fashion [45]. Although in case of POP2, the mechanism of this
inhibition is not known, POP1 interacts with IKKa, which likely
affects the downstream phosphorylation of IkBa [44]. M013
protein, on the other hand, interacts directly with NF-kB1/p105
and we postulate that this complex prevents the subsequent
nuclear translocation of p50/p65 complex at a point downstream
of IKK activation. For example, the interaction between M013
and NF-kB1 might interfere with the degradation of NF-kB1/
p105, and therefore prevent the release of active p50 and the
formation of the active p65/p50 heterodimer that subsequently
translocates to the nucleus. Thus, the vMyx-M013KO-induced
phosphorylation of IKK and degradation of IkBa raises the
possibility that deletion of MYXV-M013 from MYXV triggers
change(s) in the cellular sensing and/or responses to virus infection
such that it hinders the ability of the other viral gene products to
prevent the degradation of IkBa. Very recently, it has been shown
that a different family of ankyrin-repeat containing viral proteins,
encoded by orthpoxviruses also interacts with NF-kB1/p105 and
inhibits the activation of the NF-kB pathway [60]. This suggests
that the NF-kB1/p105 is a more common target for viral
modulation than previously appreciated.
It is not yet determined which protein domain of NF-kB1 is
involved in interaction with the M013 vPOP. Since NF-kB1 itself
lacks any PYD domain, the interaction is predicted to be
heterotypic, which has been previously observed in case of other
PYD-containing proteins [52]. It is also possible that the PYD of
M013 may interact with multiple signaling molecules in the NF-
kB pathway, based on the reported ability of PYD to enter into
heteromeric complexes and as demonstrated for ASC-1 [52]. It is
also probable that MYXV encodes multiple proteins to inhibit the
NF-kB pathway at different stages, as reported in the case of
VACV and MOCV [22,23,24,25,27]. The MYXV-encoded
ankyrin repeats (ANKs) containing protein M150 has previously
been proposed to be regulator of NF-kB function [61]. Also called
myxoma nuclear factor (MNF), M150 protein of MYXV migrated
to the nucleus in response to TNF treatment and co-localized with
NF-kB p65 [61] but to date no interacting host protein has yet
been reported for MNF/M150.
From our observations we propose that the single PYD-
containing vPOP protein M013 is able to simultaneously associate
with components from both the inflammasome complex (i.e. ASC-
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downregulate both these arms of the innate cellular pro-
inflammatory responses to virus infection. In the cellular context,
PYD-containing proteins are very important in diverse processes,
as mutations in the part of the genome that encodes certain
cellular PYD family members are connected with hereditary
diseases such as familial Mediterranean fever (FMF), familial cold
autoinflammatory syndrome (FCAS), Muckle-Wells syndrome
(MWS), and Neonatal-onset multisystem inflammatory disease
(NOMID) [62,63]. For example, the vast majority of FMF-
associated mutations are located in the C-terminal B30.2 (SPRY)
domain of the MEFV (Mediterranean Fever) gene-encoded protein
product pyrin. Any of these mutations in fact disrupt the
regulatory role of pyrin in caspase-1 activation and IL-1b
production [64,65]. In case of MYXV, the PYD domain of the
viral protein is important for the pathogenicity of the virus in vivo
and the lack of M013 expression induced a rapid early
inflammatory cytokine response (featuring caspase-1-dependent
induction of IL-1b and IL-18) in the infected host lesions [33].
The successful co-inhibition of both inflammasome activation
and NF-kB -mediated inflammatory signaling responses by a
single viral immunomodulator vPOP, M013, represents a unique
bi-functional strategy deployed by poxviruses to dampen multiple
early innate immune responses to the infecting virus. Next, it is
critical to better understand the mediator used by the host cells to
sense the infecting vMyxM013-KO virus to rapidly induce both
the inflammasome and NF-kB pro-inflammatory responses and
how the M013 vPOP protein intercepts these signals.
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